Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 146
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 2024 Brambilla, MartaZambon, Alberto + EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY - -
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 2024 Zambon, AlbertoBonanni, Luca + THE LANCET - -
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 2023 Bonanni, LucaMarcucci, RossellaZambon, Alberto + JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE - -
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries 2023 Zambon, Alberto + JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE - -
Lipid-lowering in diabetes: An update 2023 Zambon, Alberto + ATHEROSCLEROSIS - -
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 2023 Zambon Alberto + ATHEROSCLEROSIS - -
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy] 2023 Marcucci, RossellaZambon, Alberto + GIORNALE ITALIANO DI CARDIOLOGIA - -
Identifying possible homozygous familial hypercholesterolemia patients: an Italian experts' opinion 2023 Zambon, Alberto + GIORNALE ITALIANO DI CARDIOLOGIA - -
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook 2023 Zambon, Alberto + ATHEROSCLEROSIS - -
The spoils of war and the long-term spoiling of health conditions of entire nations 2022 Zambon, Alberto + ATHEROSCLEROSIS - -
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 2022 Zambon Alberto + ATHEROSCLEROSIS - -
Efficacy and safety of inclisiran a newly approved FDA drug: a systematic review and pooled analysis of available clinical studies 2022 Zambon, Alberto + AMERICAN HEART JOURNAL PLUS - -
A subgroup analysis of the ODYSSEY APPRISE study: safety and efficacy of alirocumab in the Italian cohort 2022 Zambon, Alberto + NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES - -
HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon Xanthoma 2022 Biolo, MartaScarinzi, PaoloSimioni, PaoloLupo, Maria GiovannaFerri, NicolaZambon, Alberto + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies 2022 Zambon A. + EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY - -
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome 2022 Zambon, Alberto + ATHEROSCLEROSIS - -
New and Emerging Therapies for Dyslipidemia 2022 Zambon A. + ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA - -
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients. A Statement from a European Atherosclerosis Society Task Force 2021 Zambon, Alberto + ATHEROSCLEROSIS - -
The Association of Proprotein Convertase Subtilisin/Kexin Type 9 to Plasma Low-Density Lipoproteins: An Evaluation of Different Methods 2021 Zambon, Alberto + METABOLITES - -
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: analysis on cytokines and lipid profile 2021 Lupo, Maria GiovannaArcidiacono, DilettaZaramella, AliceDe Martin, SaraZambon, AlbertoFerri, Nicola + ATHEROSCLEROSIS PLUS - -
Mostrati risultati da 1 a 20 di 146
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile